Ocuphire Pharma Inc. (OCUP)

Business: Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders.

IPO Date: 23-May-2005

Founder, CEO, Pres, Treasurer & Vice Chair of the Board: Ms. Mina Patel Sooch M.B.A., MBA

VP of Fin. & Principal Accounting Officer: Ms. Amy Zaremba Rabourn C.P.A., CPA, MAcc

Listing: NASDAQ: OCUP

Country: United States

Headquarters: Farmington Hills, MI

Website: https://www.ocuphire.com

Market cap: $36.60 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-24.27 Mln

Cash: $19.38 Mln

Total Debt: $0.22 Mln

Insider's Holding: 3.66%

Liquidity: Low

52 Week range: $1.78 - 5.50

Shares outstanding: 19,364,400